EndoPredict can be performed on estrogen-receptor-positive (ER+), HER2-negative, primary, invasive female breast tumors from patients who have not received systemic endocrine therapy and/or chemotherapy.

For more information on how to order EndoPredict, please do not hesitate to contact us or to send us an E-mail at info@positivebioscience.com and we will be pleased to guide you through the test process.